Écrit par ANSM | 05 Avril 2013

Information destinée aux neurologues, pédiatres, médecins généralistes, services d'urgences médicales, pharmaciens d'officine et hospitaliers
La spécialité Buccolam® (midazolam) a obtenu une autorisation de mise sur le marché (AMM) communautaire le 5 septembre 2011 dans le Traitement des crises convulsives aiguës prolongées chez les nourrissons, jeunes enfants, enfants et...

Écrit par Wiley | 05 Avril 2013

Researchers from the UK determined that developmental delays are present in children within six weeks following convulsive status epilepticus (CSE)—a seizure lasting longer than thirty minutes. The study appearing today in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), suggests that neurodevelopmental impairments continue to be...

Écrit par WHO | 05 Avril 2013

4 April 2013 – On 4 April 2013 (14:00 CET), the Chinese health authorities notified WHO of an additional four laboratory-confirmed cases, including three deaths, due to human infection with influenza A(H7N9). 


The three fatal cases, all men, are a 38-year-old with illness onset on 7 March 2013 from Zhejiang , a 64-year-old with illness onset on 29 March from Zhejiang, and a...

Écrit par WHO | 05 Avril 2013

3 April 2013 – On 3 April 2013, the China Health and Family Planning Commission notified WHO of an additional four cases of human infection with influenza A(H7N9).  The four patients are from Jiangsu province in eastern China.  There is no link between the cases.

The patients include a 45-year-old woman with illness onset on 19 March 2013; a 48-year-old woman with illness onset on 19...